NCT03140956View on ClinicalTrials.gov

Pharmacokinetic of Levodopa Study in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

July 3, 2017

Study Completion Date

August 3, 2017

Conditions
Parkinson Disease
Interventions
DRUG

Levodopa, carbidopa, ODM-104

Crossover design. Study treatments will be administered in randomized order 4 times a day.

Trial Locations (1)

02200

Clinical Pharmacology Unit, Orion Pharma, Espoo

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03140956 - Pharmacokinetic of Levodopa Study in Healthy Males | Biotech Hunter | Biotech Hunter